Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

Blacklisted 'Woke' Companies Gain $832 Billion During Boycotts

Consumers who don't like a company's politics can boycott their products. But ETFs trying to cash in struggle to beat the S&P 500.

Investors Business Daily

Older Americans can get RSV vaccine this fall after speaking with their doctor, CDC says

Americans 60 and older can get a new RSV vaccine but should discuss it with their doctor first

The Independent UK

'The dirty disease' – both smokers and non-smokers get lung cancer. They face stigma on top of illness

Earlier this year, federal health minister Mark Butler announced a new national Lung Cancer Screening Program. The first of its kind for lung cancer, the screening program will open initially to current and former smokers aged 50 to 70 years by July 2025. It aims to save lives by detecting…

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Supply of medicines to NZ threatened after vaccine disclosure – Ombudsman

After the Government mistakenly released confidential information about Covid-19 vaccines, the health ministry says it was 'made clear' this could have implications for broader pharmaceutical and therapeutic supply.

Newsroom.co.nz

Pfizer Stock Tumbles On 'A Big Setback' In Obesity Treatment Vs. Novo Nordisk, Eli Lilly

Pfizer stock toppled Monday after the company tossed out a potential diabetes and weight-loss drug that leads to elevated liver enzymes.

Investors Business Daily

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose

India’s first indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus will cost ₹2,292, Sanjay Singh, CEO, Gennova Biopharmaceuticals, said at a press conference on June 24.

The Hindu

What Covid has in store for winter

Pharmaceutical giant Pfizer say forewarned is forearmed when it comes to potentially spiking Covid numbers in the winter months

Newsroom.co.nz

Read news from The Economist, FT, and more,
with one subscription

Two million Brits have been taking antidepressants for five years or more

Brits' long-term dependence on anti-depressants has been laid bare as figures show a quarter of people using the drugs have been taking them for more than five years

Daily Mirror

Warren Entsch denies he helped LNP donor get Pfizer vaccine during supply crisis

Allegation raised in parliament that MP arranged for property developer Alex Sekler to travel to Torres Strait for Covid jab referred to state corruption watchdog

The Guardian - AU

MP denies quid pro quo over COVID-19 jab for donor

The federal health minister has accused Liberal MP Warren Enstch of allowing a wealthy donor to use a COVID-19 vaccine dose intended for Indigenous people.

AAP

COVID boosters should be updated to target XBB strain, US health advisers say

COVID-19 shots should be reformulated to target an XBB subvariant of the highly infectious omicron strain to provide the best protection during the U.S. fall and winter season, health regulators said.

Tribune News Service

Pfizer warns of a looming penicillin supply shortage

The shortage comes as there has been a steady increase in rates of syphilis since 2000. Inventory can start depleting as early as this month, Pfizer said.

WEKU

Pfizer Warns Of Potential Pediatric Antibiotic Shortage Amid Surge In Syphilis Infections

Pfizer Inc cautions about potential supply shortages for pediatric Bicillin L-A, an antibiotic for syphilis treatment.

Zenger

Lady Gaga raises eyebrows over paid partnership with Pfizer migraine drug

Singer is an ‘actual patient’ using the drug Nurtec ODT

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Should You Buy Into Pfizer (PFE) Today?

Despite a slowdown of Covid-19 vaccine sales in the last reported quarter, biopharmaceutical giant Pfizer (PFE) is positioned to deliver robust growth this year and beyond, thanks to the strength of its in-line products and expected near-term launches and revenue distribution from the recent acquisition. So, let’s find out if…

The Hindu

Kerala CM invites Pfizer to open research centre at Digital Sciences Park in Thiruvananthapuram

Chief Minister Pinarayi Vijayan lobbied with representatives of Pfizer, a global pharmaceutical major, to start a research wing in Kerala.

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

StockNews.com

Which Pharma Stock is a Pick for June: Pfizer (PFE) or SNDL Inc. (SNDL)?

The pharmaceutical industry is known for its resilience during challenging economic times, primarily due to the inelastic demand for essential medicines. As the specter of a potential recession hangs over the market, let us analyze two leading players in the sector, Pfizer (PFE) and SNDL (SNDL), to find the better…

Get all your
news in one place.

100’s of premium titles.
One news app.

Salon

The anti-vaxxer threat keeps spreading

With vaccines on the horizon, RSV could finally be preventable. But anti-vax misinfo could get in the way

Salon

Next COVID vax might drop OG strain

Scientists debate the benefits of bivalent and monovalent shots

Investors Business Daily

The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree

Big Pharma has a problem, and buying up biotech companies helps solve it. But the FTC has its own ideas about industry mergers. Here's where things stand.

Investors Business Daily

Pfizer's Approach To Hemophilia Is 'Certainty Differentiated' — Here's Why Shares Fell

Pfizer said Tuesday its experimental hemophilia treatment cut down on bleeding episodes in a pivotal study. But Pfizer stock dipped.

Investors Business Daily

Eli Lilly Could Launch Its Rival To Novo Nordisk's Weight-Loss Drug A Year Earlier Than Expected

An analyst expects Lilly to launch a competitor in weight-loss drugs a year earlier than expected, giving Eli Lilly stock a chance to shine.

The Independent UK

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use

U.S. health regulators have given full approval to Pfizer’s COVID-19 pill Paxlovid

StockNews.com

Buy, Sell, or Hold: Pfizer Inc. (PFE)

Pfizer (PFE) continues to make significant strides in the pharmaceutical industry, given its recent acquisition and drug approvals. Is the stock a buy, sell, or hold now? Keep reading to find out….

1 … 18 19 20 21

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.